found that the utilization of both IOTA Simple Rules and CA-125 exhibited exceptional diagnostic efficacy in distinguishing between benign and malignant ovarian tumors, surpassing the use of either CA-125 or IOTA Simple Rules individually (AUC of 0.94 for the combination tool; IOTA-SR + CA-125) (45). This evidence concerns the gene MUC16 and ovarian cancer.